XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel
· Delayed Price · Currency is ILS · Price in ILA 4.800
-0.100 (-2.04%)
Apr 28, 2025, 5:24 PM IDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 43.19 million as of April 28, 2025. Its market cap has decreased by -20.74% in one year.
Market Cap
43.19M
Enterprise Value
36.79M
Revenue
171.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.80
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 43.19M, a decrease of -94.64%. That is a compound annual growth rate of -13.82%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 61.79B |
| Danel (Adir Yeoshua) | 2.34B |
| Kamada | 1.38B |
| Bait Bakfar | 923.12M |
| Novolog (Pharm-Up 1966) | 801.51M |
| Ilex Medical | 701.77M |
| BrainsWay | 622.31M |
| SofWave Medical | 569.32M |